Product nameAnti-LYPD3 antibody [EPR9106]
See all LYPD3 primary antibodies
DescriptionRabbit monoclonal [EPR9106] to LYPD3
Tested applicationsSuitable for: WB, Flow Cytmore details
Unsuitable for: ICC/IF,IHC-P or IP
Species reactivityReacts with: Human
Synthetic peptide within Human LYPD3. The exact sequence is proprietary.
Database link: O95274
- HACAT cell lysate; BxPC-3 cell lysate and cells.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
Storage bufferPreservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant
Concentration information loading...
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab155080 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Detects a band of approximately 90 kDa (predicted molecular weight: 36 kDa).|
|Flow Cyt||1/10 - 1/100.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
FunctionSupports cell migration. May be involved in urothelial cell-matrix interactions. May be involved in tumor progression.
Tissue specificityExpressed in placenta, skin and urothelium. Found in suprabasal keratinocytes of chronic wounds. Weak expression is found in esophagus and peripheral blood mononuclear cells. Found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. High expression is found in the tumor component of some noninvasive superficial lesions and in invasive and metastatic urothelial cancers.
Sequence similaritiesContains 2 UPAR/Ly6 domains.
modificationsN-glycosylated and O-glycosylated.
Cellular localizationCell membrane.
- Information by UniProt
- 2310061G07Rik antibody
- C4.4A antibody
- GPI-anchored metastasis-associated protein C4.4A homolog antibody
All lanes : Anti-LYPD3 antibody [EPR9106] (ab155080) at 1/1000 dilution
Lane 1 : HACAT cell lysate
Lane 2 : BxPC-3 cell lysate
Lysates/proteins at 10 µg per lane.
Predicted band size: 36 kDa
Flow cytometric analysis of permeabilized BxPC-3 cells, labeling LYPD3 with ab155080 at 1/10 dilution (red) or Rabbit IgG negative control (green).
ab155080 has not yet been referenced specifically in any publications.